Skip to main content
Signal8

Royston Aaron

SEC insider (Form 3/4/5 filer). CIK 0001727703. Director at Attovia Therapeutics, Inc. (ATTO) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in BOTHELL, WA.

Companies Royston Aaron has filed insider reports for

  • Attovia Therapeutics, Inc. (ATTO): Director
  • ACHIEVE LIFE SCIENCES, INC. (ACHV): Director
Royston Aaron profile photo

Royston Aaron

CIK: 0001727703

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Attovia Therapeutics, Inc. logo
ATTO

Attovia Therapeutics, Inc.

Director
ACHIEVE LIFE SCIENCES, INC. logo
ACHV

ACHIEVE LIFE SCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Jul 27, 2026
    Award

    Stock Option (right to buy)

    Direct
    25K shares-
  • ACHIEVE LIFE SCIENCES, INC. logo
    ACHV

    ACHIEVE LIFE SCIENCES, INC.

    Jul 27, 2026
    Award

    Restricted Stock Unit (RSU)

    Direct
    16.7K shares-

1-2 of 2